These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 32748543)

  • 1. Discovery of Mitochondrial Transcription Inhibitors Active in Pancreatic Cancer Cells.
    Chen W; Hu S; Mao S; Xu Y; Guo H; Li H; Paulsen MT; Chen X; Ljungman M; Neamati N
    ChemMedChem; 2020 Nov; 15(21):2029-2039. PubMed ID: 32748543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A selective mitochondrial-targeted chlorambucil with remarkable cytotoxicity in breast and pancreatic cancers.
    Millard M; Gallagher JD; Olenyuk BZ; Neamati N
    J Med Chem; 2013 Nov; 56(22):9170-9. PubMed ID: 24147900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of 6-Fluorine-Substituted Coumarin Analogues as POLRMT Inhibitors with High Potency and Safety for Treatment of Pancreatic Cancer.
    Zhou S; Ze X; Feng D; Liu L; Shi Y; Yu M; Huang L; Wang Y; Men H; Wu J; Yuan Z; Zhou M; Xu J; Li X; Yao H
    J Med Chem; 2024 Aug; 67(15):13231-13251. PubMed ID: 39049433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triphenylphosphonium-Conjugated Palmitic Acid for Mitochondrial Targeting of Pancreatic Cancer Cells: Proteomic and Molecular Evidence.
    Siragusa G; Brandi J; Rawling T; Murray M; Cecconi D
    Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel colchicine-based microtubule inhibitor exhibits potent antitumor activity by inducing mitochondrial mediated apoptosis in MIA PaCa-2 pancreatic cancer cells.
    Kumar A; Singh B; Mahajan G; Sharma PR; Bharate SB; Mintoo MJ; Mondhe DM
    Tumour Biol; 2016 Oct; 37(10):13121-13136. PubMed ID: 27449046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mito-methyl coumarin, a novel mitochondria-targeted drug with great antitumor potential was synthesized.
    Wang H; Xu W
    Biochem Biophys Res Commun; 2017 Jul; 489(1):1-7. PubMed ID: 28546001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity relationship and mechanistic study on guggulsterone derivatives; Discovery of new anti-pancreatic cancer candidate.
    Kohyama A; Kim MJ; Yokoyama R; Sun S; Omar AM; Phan ND; Meselhy MR; Tsuge K; Awale S; Matsuya Y
    Bioorg Med Chem; 2022 Jan; 54():116563. PubMed ID: 34942553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-acute myeloid leukemia activity of 2-chloro-3-alkyl-1,4-naphthoquinone derivatives through inducing mtDNA damage and GSH depletion.
    Li K; Yang K; Zheng L; Li Y; Wang Q; Lin R; He D
    Bioorg Med Chem; 2018 Aug; 26(14):4191-4200. PubMed ID: 30007564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidovanadium(IV) Complex Disrupts Mitochondrial Membrane Potential and Induces Apoptosis in Pancreatic Cancer Cells.
    Kowalski S; Tesmar A; Sikorski A; Inkielewicz-Stępniak I
    Anticancer Agents Med Chem; 2021; 21(1):71-83. PubMed ID: 32579508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondria-targeted cancer therapy using a light-up probe with aggregation-induced-emission characteristics.
    Hu Q; Gao M; Feng G; Liu B
    Angew Chem Int Ed Engl; 2014 Dec; 53(51):14225-9. PubMed ID: 25318447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel selective mitochondrial-targeted curcumin analog with remarkable cytotoxicity in glioma cells.
    Shi L; Gao LL; Cai SZ; Xiong QW; Ma ZR
    Eur J Med Chem; 2021 Oct; 221():113528. PubMed ID: 34020339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel derivative of valepotriate inhibits the PI3K/AKT pathway and causes Noxa-dependent apoptosis in human pancreatic cancer cells.
    Yan YY; Shi KY; Teng F; Chen J; Che JX; Dong XW; Lin NM; Zhang B
    Acta Pharmacol Sin; 2020 Jun; 41(6):835-842. PubMed ID: 32047260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological Activity and Physicochemical Properties of Dipeptidyl Nitrile Derivatives Against Pancreatic Ductal Adenocarcinoma Cells.
    Quilles JC; Bernardi MDL; Batista PHJ; Silva SCM; Rocha CMR; Montanari CA; Leitão A
    Anticancer Agents Med Chem; 2019; 19(1):112-120. PubMed ID: 30370859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and synthesis of diosgenin derivatives as apoptosis inducers through mitochondria-related pathways.
    Ma L; Zhang J; Wang X; Yang J; Guo L; Wang X; Song B; Dong W; Wang W
    Eur J Med Chem; 2021 May; 217():113361. PubMed ID: 33740546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth inhibition and mechanism of action of p-dodecylaminophenol against refractory human pancreatic cancer and cholangiocarcinoma.
    Imai M; Takahashi N
    Bioorg Med Chem; 2012 Apr; 20(8):2520-6. PubMed ID: 22440084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Hybrid-polar Histone Deacetylase Inhibitor m-Carboxycinnamic Acid bis-Hydroxyamide on Human Pancreatic Adenocarcinoma Cells.
    Kumar D; Sarma P; Bhadra MP; Tangutur AD
    Anticancer Agents Med Chem; 2019; 19(6):750-759. PubMed ID: 30621566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rational design of mitochondria-targeted pyruvate dehydrogenase kinase 1 inhibitors with improved selectivity and antiproliferative activity.
    Xu B; Yu Z; Xiang S; Li Y; Zhang SL; He Y
    Eur J Med Chem; 2018 Jul; 155():275-284. PubMed ID: 29890389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KRas4B-PDE6δ complex stabilization by small molecules obtained by virtual screening affects Ras signaling in pancreatic cancer.
    Casique-Aguirre D; Briseño-Díaz P; García-Gutiérrez P; la Rosa CHG; Quintero-Barceinas RS; Rojo-Domínguez A; Vergara I; Medina LA; Correa-Basurto J; Bello M; Hernández-Rivas R; Del RocioThompson-Bonilla M; Vargas M
    BMC Cancer; 2018 Dec; 18(1):1299. PubMed ID: 30594165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and discovery of novel quinazolinedione-based redox modulators as therapies for pancreatic cancer.
    Pathania D; Sechi M; Palomba M; Sanna V; Berrettini F; Sias A; Taheri L; Neamati N
    Biochim Biophys Acta; 2014 Jan; 1840(1):332-43. PubMed ID: 23954204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modified Metformin as a More Potent Anticancer Drug: Mitochondrial Inhibition, Redox Signaling, Antiproliferative Effects and Future EPR Studies.
    Kalyanaraman B; Cheng G; Hardy M; Ouari O; Sikora A; Zielonka J; Dwinell MB
    Cell Biochem Biophys; 2017 Dec; 75(3-4):311-317. PubMed ID: 28429253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.